Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company DiaMedica Inc.
DescriptionMouse mAb that indirectly inhibits glycogen synthase kinase 3 (GSK3) beta activity
Molecular Target Glycogen dependent kinase 3 (GSK3)
Mechanism of ActionGlycogen synthase kinase 3 (GSK3) beta inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today